Retractable Technologies
About: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.
Employees: 227
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
5% more capital invested
Capital invested by funds: $1.54M [Q4 2024] → $1.63M (+$82.9K) [Q1 2025]
0.23% more ownership
Funds ownership: 7.49% [Q4 2024] → 7.71% (+0.23%) [Q1 2025]
0% more funds holding
Funds holding: 30 [Q4 2024] → 30 (+0) [Q1 2025]
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Research analyst outlook
We haven’t received any recent analyst ratings for RVP.
Financial journalist opinion









